Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation

The authors of this study evaluated the effectiveness of CHA2DS2-VASc and CHADS2 scores compared with ATRIA score for predicting stroke risk in 60,594 patients with atrial fibrillation not on warfarin. The ATRIA score had a C statistic of 0.70, which was slightly higher than the C statistic of 0.68 for both the CHADS2 and CHA2DS2-VASc scores. Compared with CHA2DS2-VASc, ATRIA had a positive net reclassification improvement of 0.23.

ATRIA may be better at predicting the risk of stroke in patients with atrial fibrillation than CHADS2 or CHA2DS2-VASc.

A cura di Calogero Calcullo

J Am Coll Cardiol. 2015;66(17):1851-1859. doi:10.1016/j.jacc.2015.08.033

http://content.onlinejacc.org/article.aspx?articleid=2461789

 

Rubriche

RAPPORTO STRETTO TRA COVID-19 E IPERTENSIONE

Giuseppe Trisolino – Spec. in Cardiologia, Segretario Regionale ANCE Emilia-Romagna L'epidemia di coronavirus 2019 (COVID-19) rimane una delle principali sfide per la salute pubblica in tutto il mondo. Con la crescente comprensione della fisiopatologia di questa...